An oral form of methylglyoxal-bis-guanylhydrazone reduces monocyte activation and traffic to the dorsal root ganglia in a primate model of HIV-peripheral neuropathy

Documenti analoghi

• Monocyte Traffic, Dorsal Root Ganglion Histopathology, and Loss of Intraepidermal Nerve Fiber Density in SIV Peripheral Neuropathy
  di: Lakritz, Jessica R., et al.
  Pubblicazione: (2015)
• Methylglyoxal-bis-guanylhydrazone inhibits osteopontin expression and differentiation in cultured human monocytes
  di: Jin, Xia, et al.
  Pubblicazione: (2018)
• Direct Targeting of Macrophages with Methylglyoxal-Bis-Guanylhydrazone Decreases SIV-Associated Cardiovascular Inflammation and Pathology
  di: Walker, Joshua A., et al.
  Pubblicazione: (2017)
• Inhibition of HIV Expression and Integration in Macrophages by Methylglyoxal-Bis-Guanylhydrazone
  di: Jin, Xia, et al.
  Pubblicazione: (2015)
• α4-Integrin Antibody Treatment Blocks Monocyte/Macrophage Traffic to, Vascular Cell Adhesion Molecule-1 Expression in, and Pathology of the Dorsal Root Ganglia in an SIV Macaque Model of HIV-Peripheral Neuropathy
  di: Lakritz, Jessica R., et al.
  Pubblicazione: (2016)